// company-profile

AN2 Therapeutics, Inc.

ANTX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings136Insiders26
// api This AN2 Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bearish. Over the last 30 days, insiders net sold $1K across 1 transaction.

// 90-day insight

Over the last 90 days, AN2 Therapeutics, Inc. insiders bought $0 (3 transactions) and sold $1K (1 transaction).

  • Most active insider: Williams Sarah Joanne with 1 transaction totaling $1K.
  • Largest single sale: $1K by Williams Sarah Joanne on May 29, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of AN2 Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$74.2M
QoQ change
+680.0%
Reporting period
2026-03-31
#1
Vivo Capital, LLC
CIK 1674712
$10.8M
3.2M shares
#2
Commodore Capital LP
CIK 1831942
$8.0M
2.3M shares
#3
MILLENNIUM MANAGEMENT LLC
CIK 1273087
$7.6M
2.2M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 29, 2026Williams Sarah JoanneANTX
Sale
265$4.43$1K
Apr 10, 2026Aziz KabeerANTX
Award
3,775$0.00$0K
Apr 10, 2026Marks Gilbert LynnANTX
Award
3,775$0.00$0K
Apr 10, 2026Martin Patricia A.ANTX
Award
1,192$0.00$0K
Mar 19, 2026Martin Patricia A.ANTX
Disposition
23,742

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.